Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$890K Sell
4,774
-320
-6% -$56.7K 0.09% 93
2017
Q2
$877K Hold
5,094
0.09% 90
2017
Q1
$836K Sell
5,094
-22,119
-81% -$3.68M 0.09% 89
2016
Q4
$3.98M Buy
27,213
+2,375
+10% +$357K 0.44% 29
2016
Q3
$4.14M Buy
24,838
+552
+2% +$93.3K 0.45% 22
2016
Q2
$3.69M Buy
24,286
+59
+0.2% +$9.17K 0.41% 27
2016
Q1
$3.63M Buy
24,227
+1,456
+6% +$216K 0.44% 27
2015
Q4
$3.7M Buy
22,771
+1,326
+6% +$208K 0.46% 26
2015
Q3
$2.97M Buy
21,445
+1,778
+9% +$280K 0.38% 29
2015
Q2
$3.02M Buy
19,667
+14,784
+303% +$2.37M 0.34% 29
2015
Q1
$781K Hold
4,883
0.08% 108
2014
Q4
$778K Hold
4,883
0.08% 111
2014
Q3
$686K Hold
4,883
0.07% 117
2014
Q2
$578K Hold
4,883
0.06% 139
2014
Q1
$602K Hold
4,883
0.07% 132
2013
Q4
$557K Hold
4,883
0.06% 136
2013
Q3
$547K Hold
4,883
0.06% 125
2013
Q2
$482K Buy
+4,883
New +$507K 0.06% 131

Other funds holding AMGN

BancorpSouth's AMGN Position: Q3 2017 in Review

BancorpSouth reduced its Amgen (AMGN) stake by 6.3% in Q3 2017, selling an estimated $56.7K and leaving 4,774 shares worth $890K. The position accounts for 0.09% of the portfolio, ranked #93.

BancorpSouth first reported a position in AMGN in Q2 2013 and has held it in 18 quarters since. The position peaked at $4.14M in Q3 2016. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • BancorpSouth held 4,774 shares of Amgen worth $890K as of Q3 2017.
  • BancorpSouth sold 320 Amgen shares in Q3 2017, an estimated $56.7K.
  • Amgen made up 0.09% of BancorpSouth's portfolio in Q3 2017, its #93 holding.
  • BancorpSouth first reported a position in Amgen in Q2 2013 and has held it in 18 quarters since.
  • BancorpSouth's Amgen position peaked at $4.14M in Q3 2016.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.